leisure time -WSS

leisure time

author：focus 2025-08-12 11:30:06 - browse：478

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Timeline: Key moments in fight for gay rights

focus

WSS

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

J&J expands global access to TB drug amid advocacy campaign

Millions may soon lose Medicaid when they don't have to

Global childhood vaccinations edge closer to pre

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Federal judge rules Oregon’s tough new gun law is constitutional

hotspot

leisure time

hotspot

In Memoriam: Notable people who died in 2023

FDA approves first new drug developed for postpartum depression

The high cost of giving birth even with insurance

Millions may soon lose Medicaid when they don't have to

ChatGPT in medicine: STAT answers readers' burning questions

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Supreme Court strikes down use of affirmative action

Argenx drug significantly slows progression of nerve disorder

United colonoscopy coverage change 'may cost lives,' doctors say

Senate panel passes drug pricing bills, but drops one PBM reform

focus

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Timeline: Key moments in fight for gay rights

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Biden administration plans revamp of organ transplant system

Europe sees delivery challenges ahead on Alzheimer's therapies

Congress likely to miss an opportunity to fix drug shortages issue

focus

focus

leisure time

hotspot